Atlas Trials

A Study to Assess the Pharmacokinetic Profile, the Safety, and the Tolerability of ME1100 Inhalation Solution in Patients With Mechanically Ventilated Bacterial Pneumonia

Clinical trial NCT02459158 · COMPLETED

Trial details

NCT number
NCT02459158
Sponsor
Meiji Seika Pharma Co., Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Pneumonia, Bacterial
Start date
2015-09-01
Primary completion
2017-03-22
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.